Anthelmintic Drugs as Emerging Immune Modulators in Cancer

Despite recent advances in treatment approaches, cancer is still one of the leading causes of death worldwide. Restoration of tumor immune surveillance represents a valid strategy to overcome the acquired resistance and cytotoxicity of conventional therapies in oncology and immunotherapeutic drugs,...

Descripción completa

Detalles Bibliográficos
Autores principales: Stolfi, Carmine, Pacifico, Teresa, Luiz-Ferreira, Anderson, Monteleone, Giovanni, Laudisi, Federica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10094506/
https://www.ncbi.nlm.nih.gov/pubmed/37047419
http://dx.doi.org/10.3390/ijms24076446

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10094506/
https://www.ncbi.nlm.nih.gov/pubmed/37047419
http://dx.doi.org/10.3390/ijms24076446

Ejemplares similares